The G-BA assesses the additional clinical benefit relative to an appropriate comparator therapy
Retatrutide targets three hormone receptors : GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and glucagon
Indiana University-Purdue University Indianapolis
After final selection, data were extracted by three investigators (XX, PPZ, and CXF) from the eligible case reports, which included first authors name, year of publication, country, patient sex and age, medical history, indication for medication, route of administration, dosage, concomitant medications, ADRs, diagnosis, time to ADR onset, clinical presentation, drug re-exposure, intervention measures, laboratory parameters, such as blood urea nitrogen (BUN), serum creatinine (SCr), estimated glomerular filtration rate (eGFR), urine protein-to-creatinine ratio (UPCR), and proteinuria, and patient outcomes